Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

1.

Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.

Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, Hughes S, Johnson P, Wood KJ.

Transplantation. 2013 Oct 27;96(8):707-16. doi: 10.1097/TP.0b013e31829fa271.

PMID:
23917725
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice.

Yi S, Ji M, Wu J, Ma X, Phillips P, Hawthorne WJ, O'Connell PJ.

Diabetes. 2012 May;61(5):1180-91. doi: 10.2337/db11-1306. Epub 2012 Mar 8.

PMID:
22403295
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.

Feng G, Wood KJ, Bushell A.

Transplantation. 2008 Aug 27;86(4):578-89. doi: 10.1097/TP.0b013e3181806a60.

PMID:
18724229
[PubMed - indexed for MEDLINE]
4.

Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.

Deng R, Khattar M, Xie A, Schroder PM, He X, Chen W, Stepkowski SM.

Transplantation. 2014 Jun 27;97(12):1216-24. doi: 10.1097/TP.0000000000000120.

PMID:
24854475
[PubMed - indexed for MEDLINE]
5.

Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.

Yolcu ES, Zhao H, Bandura-Morgan L, Lacelle C, Woodward KB, Askenasy N, Shirwan H.

J Immunol. 2011 Dec 1;187(11):5901-9. doi: 10.4049/jimmunol.1003266. Epub 2011 Nov 7.

PMID:
22068235
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.

Xia G, He J, Zhang Z, Leventhal JR.

Transplantation. 2006 Dec 27;82(12):1749-55.

PMID:
17198271
[PubMed - indexed for MEDLINE]
7.

Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells.

Francis RS, Feng G, Tha-In T, Lyons IS, Wood KJ, Bushell A.

Eur J Immunol. 2011 Mar;41(3):726-38. doi: 10.1002/eji.201040509. Epub 2011 Jan 17.

PMID:
21243638
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Anergic T cells generated in vitro suppress rejection response to islet allografts.

Luo Z, Gotoh M, Grochowiecki T, Tanaka T, Kimura F, Kawashima H, Yagita H, Okumura K, Miyasaka M.

Transplantation. 2000 May 27;69(10):2144-8.

PMID:
10852614
[PubMed - indexed for MEDLINE]
9.

[Homing of CFSE-labeled antigen-specific CD4(+)CD25(+) regulatory T cells in islets transplantation].

Zhang M, Xu SH, Xu Y, Liu CP, Mao XD, Xu KF, Liu C.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Dec;24(12):1174-6. Chinese.

PMID:
19068204
[PubMed - indexed for MEDLINE]
10.

Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.

Banuelos SJ, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL, Rossini AA, Appel MC.

Clin Immunol. 2004 Sep;112(3):273-83.

PMID:
15308121
[PubMed - indexed for MEDLINE]
11.

Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts.

Khattar M, Deng R, Kahan BD, Schroder PM, Phan T, Rutzky LP, Stepkowski SM.

Transplantation. 2013 Apr 15;95(7):919-27. doi: 10.1097/TP.0b013e3182842396.

PMID:
23545505
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.

Stepkowski SM, Phan T, Zhang H, Bilinski S, Kloc M, Qi Y, Katz SM, Rutzky LP.

Transplantation. 2006 Dec 27;82(12):1756-63.

PMID:
17198272
[PubMed - indexed for MEDLINE]
13.

Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.

Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K.

Transplantation. 2010 Dec 27;90(12):1321-7. doi: 10.1097/TP.0b013e3181ff8772.

PMID:
21048528
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.

Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF.

Cell Transplant. 1999 Jul-Aug;8(4):375-81.

PMID:
10478717
[PubMed - indexed for MEDLINE]
15.

Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.

Vlad G, D'Agati VD, Zhang QY, Liu Z, Ho EK, Mohanakumar T, Hardy MA, Cortesini R, Suciu-Foca N.

Diabetes. 2008 Jul;57(7):1878-86. doi: 10.2337/db08-0054. Epub 2008 Apr 16.

PMID:
18420485
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.

Lee I, Wang L, Wells AD, Ye Q, Han R, Dorf ME, Kuziel WA, Rollins BJ, Chen L, Hancock WW.

J Immunol. 2003 Dec 15;171(12):6929-35.

PMID:
14662900
[PubMed - indexed for MEDLINE]
Free Article
17.

Selective depletion of alloreactive T cells leads to long-term islet allograft survival across a major histocompatibility complex mismatch in diabetic mice.

Hu M, Wu J, Zhang GY, Wang YM, Watson D, Yi S, Hawthorne WJ, O'Connell PJ, Alexander SI.

Cell Transplant. 2013;22(10):1929-41. doi: 10.3727/096368912X658025. Epub 2012 Oct 25.

PMID:
23107388
[PubMed - indexed for MEDLINE]
18.

Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.

Xia G, He J, Leventhal JR.

Am J Transplant. 2008 Feb;8(2):298-306. doi: 10.1111/j.1600-6143.2007.02088.x. Epub 2008 Jan 7.

PMID:
18190656
[PubMed - indexed for MEDLINE]
Free Article
19.

Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.

Elpek KG, Yolcu ES, Franke DD, Lacelle C, Schabowsky RH, Shirwan H.

J Immunol. 2007 Dec 1;179(11):7295-304.

PMID:
18025172
[PubMed - indexed for MEDLINE]
Free Article
20.

Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.

Abdi R, Means TK, Ito T, Smith RN, Najafian N, Jurewicz M, Tchipachvili V, Charo I, Auchincloss H Jr, Sayegh MH, Luster AD.

J Immunol. 2004 Jan 15;172(2):767-75.

PMID:
14707046
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk